SCHEMBL27123871

SCHEMBL27123871

O=[N+]([O-])c1ccc(NN=Cc2c[nH]c3ccccc23)cc1

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MEN1 O00255 12/20 1.00
▸ KMT2A Q03164 12/20 1.00
▸ GAA P10253 6/20 1.00
▸ MAPT P10636 5/20 1.00
▸ PSMD14 O00487 2/20 1.00
▸ TLR9 Q9NR96 1/20 1.00
▸ SENP7 Q9BQF6 9/20 0.69
▸ SENP8 Q96LD8 7/20 0.67
▸ SENP6 Q9GZR1 7/20 0.67
▸ CASP3 P42574 5/20 0.67
▸ L3MBTL1 Q9Y468 3/20 0.67
▸ NPC1 O15118 3/20 0.67
▸ SMN1; SMN2 Q16637 2/20 0.67
▸ TDP1 Q9NUW8 2/20 0.67
▸ CYP1A2 P05177 1/20 0.67
▸ CYP3A4 P08684 1/20 0.67
▸ CYP2D6 P10635 1/20 0.67
▸ CYP2C9 P11712 1/20 0.67
▸ CYP2C19 P33261 1/20 0.67
▸ KLF5 Q13887 1/20 0.65

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26983136 1.00 MEN1 (1.00) MEN1KMT2AGAAMAPTPSMD14
SCHEMBL8977733 0.82 MEN1 (0.70) MEN1KMT2AGAAMAPTPSMD14
SCHEMBL8977730 0.82 MEN1 (0.70) MEN1KMT2AGAAMAPTPSMD14
SCHEMBL24629300 0.82 SENP7 (1.00) MEN1KMT2AGAAMAPTPSMD14
SCHEMBL27139059 0.82 SENP7 (1.00) MEN1KMT2AGAAMAPTPSMD14
SCHEMBL27126553 0.80 SENP7 (1.00) MEN1KMT2AGAAMAPTPSMD14
SCHEMBL24629299 0.80 SENP7 (1.00) MEN1KMT2AGAAMAPTPSMD14
SCHEMBL4639506 0.80 CA12 (0.73) MEN1KMT2AGAAMAPTPSMD14
SCHEMBL4639508 0.80 CA12 (0.73) MEN1KMT2AGAAMAPTPSMD14
SCHEMBL24629301 0.79 SENP7 (1.00) MEN1KMT2AGAAMAPTPSMD14

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240010619-A1 SMALL MOLECULES WITH ANTIBACTERIAL ACTIVITY NEW MEXICO TECH UNIVERSITY RESEARCH PARK CORPORATION 2024-01-11 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240010619-A1 SMALL MOLECULES WITH ANTIBACTERIAL ACTIVITY CLPP, MRPL21, TIAL1 MEN1 4408/4885KMT2A 4266/4885GAA 271/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback